First-in-class Biologic Agent for Kidney Transplant Rejection Approved in Europe - SYS-CON Media (press release) PDF Print
SYS-CON Media (press release)
By acting selectively on the immune system to prevent graft rejection, belatacept helps safeguard renal function, which is increasingly recognized as a key predictor of long term outcomes in kidney transplant recipients, impacting both patient and

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.